MA27549A1 - N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones - Google Patents
N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridonesInfo
- Publication number
- MA27549A1 MA27549A1 MA28270A MA28270A MA27549A1 MA 27549 A1 MA27549 A1 MA 27549A1 MA 28270 A MA28270 A MA 28270A MA 28270 A MA28270 A MA 28270A MA 27549 A1 MA27549 A1 MA 27549A1
- Authority
- MA
- Morocco
- Prior art keywords
- pyridone
- sulfonyl
- methylene
- hydroxy
- amino
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La présente invention concerne des composés de formule (I) efficaces pour traiter une infection microbienne.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42507102P | 2002-11-09 | 2002-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27549A1 true MA27549A1 (fr) | 2005-10-03 |
Family
ID=32312927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28270A MA27549A1 (fr) | 2002-11-09 | 2005-05-09 | N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6946479B2 (fr) |
| EP (1) | EP1558580B1 (fr) |
| JP (1) | JP4327730B2 (fr) |
| KR (2) | KR100894237B1 (fr) |
| CN (1) | CN1708482A (fr) |
| AT (1) | ATE372986T1 (fr) |
| AU (1) | AU2003296045B2 (fr) |
| BR (1) | BR0316086A (fr) |
| CA (1) | CA2502416C (fr) |
| CO (1) | CO5570702A2 (fr) |
| CY (1) | CY1106957T1 (fr) |
| DE (1) | DE60316339T2 (fr) |
| DK (1) | DK1558580T3 (fr) |
| ES (1) | ES2293059T3 (fr) |
| HR (1) | HRP20050517B1 (fr) |
| IL (1) | IL168118A (fr) |
| MA (1) | MA27549A1 (fr) |
| MX (1) | MXPA05004897A (fr) |
| NO (1) | NO331012B1 (fr) |
| NZ (1) | NZ539385A (fr) |
| PL (1) | PL377176A1 (fr) |
| PT (1) | PT1558580E (fr) |
| RU (1) | RU2321584C2 (fr) |
| WO (1) | WO2004043928A2 (fr) |
| ZA (1) | ZA200503682B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6946479B2 (en) * | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| US6930117B2 (en) * | 2002-11-09 | 2005-08-16 | The Procter & Gamble Company | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| US20070275944A1 (en) * | 2006-04-05 | 2007-11-29 | The Board Of Trustees Operating Michigan State University | Antioxidants and methods of their use |
| US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
| MY160399A (en) | 2009-07-06 | 2017-03-15 | Aerpio Therapeutics Inc | Compounds, compositions, and methods for preventing metastasis of cancer cells |
| EP3698794A1 (fr) * | 2009-11-06 | 2020-08-26 | Aerpio Therapeutics, Inc. | Compositions et procédés pour le traitement de la colite |
| CN104136026B (zh) | 2011-10-31 | 2018-03-02 | 卫理公会医院研究所 | 包含mao靶向/探寻器部分的人神经胶质瘤治疗用化合物 |
| CN103360308A (zh) * | 2012-03-28 | 2013-10-23 | 孙伟新 | 1,4-二羟基-6-甲基-2-吡啶酮类化合物及其制备方法和用途 |
| US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
| AU2014233363B2 (en) | 2013-03-15 | 2017-06-29 | EyePoint, Inc. | Compositions, formulations and methods for treating ocular diseases |
| JP6549140B2 (ja) | 2014-02-19 | 2019-07-24 | エアーピオ セラピューティクス インコーポレイテッド | Ｎ−ベンジル−３−ヒドロキシ−４−置換ピリジン−２−（１ｈ）−オン |
| EP3116503A4 (fr) | 2014-03-14 | 2017-08-23 | Aerpio Therapeutics, Inc. | Inhibiteurs de hptp-bêta |
| WO2016022813A1 (fr) | 2014-08-07 | 2016-02-11 | Aerpio Therapeutics, Inc. | Combinaison d'immunothérapies avec des activateurs de tie -2 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3853900A (en) | 1973-09-14 | 1974-12-10 | Searle & Co | 4-benzyloxy-2 (1h)-pyridones |
| US5358949A (en) * | 1986-03-05 | 1994-10-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives |
| DE4316077A1 (de) * | 1993-05-13 | 1994-11-17 | Bayer Ag | Substituierte Mono- und Bihydridylmethylpyridone |
| US5817825A (en) * | 1994-11-02 | 1998-10-06 | Hoechst Aktiengesellschaft | Process for the preparation of 1-hydroxy-2-pyridones |
| US6046219A (en) * | 1995-01-20 | 2000-04-04 | Cornell Research Foundation, Inc. | Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation |
| US5789426A (en) * | 1995-01-20 | 1998-08-04 | Cornell Research Foundation, Inc. | Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
| US5849587A (en) * | 1995-06-09 | 1998-12-15 | Cornell Research Foundation, Inc. | Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| US6946479B2 (en) * | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
-
2003
- 2003-11-06 US US10/703,067 patent/US6946479B2/en not_active Expired - Fee Related
- 2003-11-07 NZ NZ539385A patent/NZ539385A/en not_active IP Right Cessation
- 2003-11-07 CA CA2502416A patent/CA2502416C/fr not_active Expired - Fee Related
- 2003-11-07 ES ES03783256T patent/ES2293059T3/es not_active Expired - Lifetime
- 2003-11-07 PT PT03783256T patent/PT1558580E/pt unknown
- 2003-11-07 AT AT03783256T patent/ATE372986T1/de active
- 2003-11-07 AU AU2003296045A patent/AU2003296045B2/en not_active Ceased
- 2003-11-07 DE DE60316339T patent/DE60316339T2/de not_active Expired - Lifetime
- 2003-11-07 EP EP03783256A patent/EP1558580B1/fr not_active Expired - Lifetime
- 2003-11-07 KR KR1020077004211A patent/KR100894237B1/ko not_active Expired - Fee Related
- 2003-11-07 RU RU2005114490/04A patent/RU2321584C2/ru not_active IP Right Cessation
- 2003-11-07 DK DK03783256T patent/DK1558580T3/da active
- 2003-11-07 KR KR1020057007516A patent/KR20050055793A/ko not_active Ceased
- 2003-11-07 PL PL377176A patent/PL377176A1/pl unknown
- 2003-11-07 HR HRP20050517AA patent/HRP20050517B1/hr not_active IP Right Cessation
- 2003-11-07 JP JP2004551914A patent/JP4327730B2/ja not_active Expired - Fee Related
- 2003-11-07 MX MXPA05004897A patent/MXPA05004897A/es active IP Right Grant
- 2003-11-07 BR BR0316086-6A patent/BR0316086A/pt not_active IP Right Cessation
- 2003-11-07 CN CNA200380102221XA patent/CN1708482A/zh active Pending
- 2003-11-07 WO PCT/US2003/035623 patent/WO2004043928A2/fr not_active Ceased
-
2005
- 2005-04-19 IL IL168118A patent/IL168118A/en not_active IP Right Cessation
- 2005-05-09 MA MA28270A patent/MA27549A1/fr unknown
- 2005-05-09 ZA ZA200503682A patent/ZA200503682B/en unknown
- 2005-05-24 CO CO05050160A patent/CO5570702A2/es active IP Right Grant
- 2005-06-09 NO NO20052788A patent/NO331012B1/no not_active IP Right Cessation
- 2005-06-14 US US11/151,897 patent/US7247632B2/en not_active Expired - Fee Related
-
2007
- 2007-06-18 US US11/820,097 patent/US20070238722A1/en not_active Abandoned
- 2007-10-25 CY CY20071101382T patent/CY1106957T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27771A1 (fr) | 5,7-diaminopyrazolo[4,3-d]pyrimidines utiles dans le traitement de l'hypertension | |
| GB0127903D0 (en) | Improvements relating to organic compounds | |
| HRP20050516B1 (hr) | N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi | |
| NO20041493L (no) | Kjemiske forbindelser. | |
| MA30427B1 (fr) | Derives bicycliques utilises comme inhibiteurs de cetp | |
| EA200601007A1 (ru) | 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы | |
| CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
| MA27549A1 (fr) | N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones | |
| NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
| ATE368040T1 (de) | Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren | |
| SE0103710D0 (sv) | Compounds | |
| DE60220385D1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| EA200600330A1 (ru) | Замещённые имидазопиримидины для предупреждения и лечения рака | |
| TR200002932T2 (tr) | Azabisayklik 5HT1 Alıcı liganolları | |
| EA200400454A1 (ru) | Мускариновые агонисты | |
| MA64568B1 (fr) | Composés hétérocycliques capables d'activer sting | |
| WO2001091796A8 (fr) | Methodes, composes et compositions permettant de traiter la goutte | |
| DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
| BRPI0416678A (pt) | pirazolpirimidinas | |
| DE60325984D1 (de) | 4-aminobenzofuranverbindungen als phosphodiesterase-4-inhibitoren | |
| ATE346040T1 (de) | Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit | |
| MA27846A1 (fr) | Nouveaux bioisosteres d'actinonine | |
| GB0103045D0 (en) | Organic Compounds | |
| EA200601106A1 (ru) | Трициклические имидазопиридины для применения в качестве ингибиторов желудочной секреции | |
| ATE455097T1 (de) | Neue derivate von 4,4'-dithiobis-(3-aminobutan-1- sulfonaten) und diese enthaltende zusammensetzungen |